(Q33753315)

29 July 2017

1 reference

title

Lamotrigine and the treatment of mania in bipolar disorder (English)

1 reference

29 July 2017

1 reference

1 reference

1

1 reference

PubMed ID

10524838

29 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

European Neuropsychopharmacology

29 July 2017

1 reference

29 July 2017

9 Suppl 4

1 reference

29 July 2017

S119-23

1 reference

The platelet intracellular calcium response to serotonin is augmented in bipolar manic and depressed patients

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Supersensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Olanzapine compared to lithium in mania: a double-blind randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Lymphoblastoid transmembrane potential in bipolar patients, their siblings, and unrelated healthy comparison subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Lithium: balancing risks and benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Lamotrigine treatment of refractory bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Erythrocyte sodium pump activity in bipolar affective disorder and other psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Effects of lamotrigine on the 5-HT1A receptor function in healthy human males.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Differential Treatment of Bipolar Disorder with Old and New Antiepileptic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900025-5

7 January 2021

10.1016/S0924-977X(99)00025-5

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10524838